The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide
The aim of the study is to compare the efficacy of SPIO as a tracer in sentinel node biopsy (SNB) in breast cancer with Tc and patent blue in a multicentre prospective study and perform a meta-analysis of all published studies. It also aims to follow skin discoloration after SPIO injection and descr...
Saved in:
Published in | Breast cancer research and treatment Vol. 157; no. 2; p. 281 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Springer
01.06.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The aim of the study is to compare the efficacy of SPIO as a tracer in sentinel node biopsy (SNB) in breast cancer with Tc and patent blue in a multicentre prospective study and perform a meta-analysis of all published studies. It also aims to follow skin discoloration after SPIO injection and describe when and how it resolves. Totally 206 patients with early breast cancer were recruited. Tc and patent blue were administered in standard fashion. Patients were injected with SPIO (Sienna+) preoperatively. SNB was performed and detection rates were recorded for both methods. Skin discoloration was followed and documented postoperatively. Data extraction and subsequent meta-analysis of all previous studies were also performed. SN detection rates were similar between standard technique succeeded and SPIO both per patient (97.1 vs. 97.6 %, p = 0.76) as well as per node (91.3 vs. 93.3 %, p = 0.34), something which was not affected by the presence of malignancy. Concordance rates were also consistently high (98.0 % per patient and 95.9 % per node). Discoloring was present in 35.5 % of patients postoperatively, almost exclusively in breast conservation. It fades slowly and is still detectable in 8.6 % of patients after 15 months. Meta-analysis depicted similar detection rates (p = 0.71) and concordance rates (p = 0.82) per patient. However, it seems that SPIO is characterized by higher nodal retrieval (p < 0.001). SPIO is an effective method for the detection of SN in patients with breast cancer. It is comparable to the standard technique and seems to simplify logistics. Potential skin discoloration is something of consideration in patients planned for breast conservation. |
---|---|
AbstractList | The aim of the study is to compare the efficacy of SPIO as a tracer in sentinel node biopsy (SNB) in breast cancer with Tc and patent blue in a multicentre prospective study and perform a meta-analysis of all published studies. It also aims to follow skin discoloration after SPIO injection and describe when and how it resolves. Totally 206 patients with early breast cancer were recruited. Tc and patent blue were administered in standard fashion. Patients were injected with SPIO (Sienna+) preoperatively. SNB was performed and detection rates were recorded for both methods. Skin discoloration was followed and documented postoperatively. Data extraction and subsequent meta-analysis of all previous studies were also performed. SN detection rates were similar between standard technique succeeded and SPIO both per patient (97.1 vs. 97.6 %, p = 0.76) as well as per node (91.3 vs. 93.3 %, p = 0.34), something which was not affected by the presence of malignancy. Concordance rates were also consistently high (98.0 % per patient and 95.9 % per node). Discoloring was present in 35.5 % of patients postoperatively, almost exclusively in breast conservation. It fades slowly and is still detectable in 8.6 % of patients after 15 months. Meta-analysis depicted similar detection rates (p = 0.71) and concordance rates (p = 0.82) per patient. However, it seems that SPIO is characterized by higher nodal retrieval (p < 0.001). SPIO is an effective method for the detection of SN in patients with breast cancer. It is comparable to the standard technique and seems to simplify logistics. Potential skin discoloration is something of consideration in patients planned for breast conservation. |
Audience | Academic |
Author | Jørnsgård, Hjørdis Fischer, Lone Bergkvist, Leif Rasmussen, Nils Ryegaard Daskalakis, Kosmas Christiansen, Peer Michael Hedin, Christina Tegnelius, Daniel Wärnberg, Fredrik Sund, Malin Markopoulos, Christos J Pistioli, Lida Eriksson, Staffan Karakatsanis, Andreas |
Author_xml | – sequence: 1 fullname: Karakatsanis, Andreas – sequence: 1 fullname: Christiansen, Peer Michael – sequence: 1 fullname: Sund, Malin – sequence: 1 fullname: Rasmussen, Nils Ryegaard – sequence: 1 fullname: Wärnberg, Fredrik – sequence: 1 fullname: Bergkvist, Leif – sequence: 1 fullname: Jørnsgård, Hjørdis – sequence: 1 fullname: Tegnelius, Daniel – sequence: 1 fullname: Fischer, Lone – sequence: 1 fullname: Pistioli, Lida – sequence: 1 fullname: Markopoulos, Christos J – sequence: 1 fullname: Hedin, Christina – sequence: 1 fullname: Daskalakis, Kosmas – sequence: 1 fullname: Eriksson, Staffan |
BookMark | eNqNi70OgjAURjtgIqjvcCc3koL8iJsxGhZdZCc3cIGa0pK2JD6-mPgATl9yzvkC5imtyGM-j7I8zI48W7PA2hfnvMh54bOyGgge2rSigScpJ-7YgzMC5QkQGj1OaITVCnQHdp7IwAJwxF6RWy7CfNVbtLRlqw6lpd1vN2x_u1aXMuxRUj0QSjdYLWcntLL1OUnjPE6TKDn8HX4Aa0o_EQ |
ContentType | Journal Article |
Copyright | COPYRIGHT 2016 Springer |
Copyright_xml | – notice: COPYRIGHT 2016 Springer |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | A452725414 |
GroupedDBID | --- -53 -5E -5G -BR -EM -~C .86 .VR 06C 06D 0R~ 0VY 199 1N0 203 23N 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2~H 30V 3V. 4.4 406 408 409 40D 40E 5GY 5VS 67Z 6NX 78A 7X7 88E 8AO 8C1 8FI 8FJ 8G5 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO ABAKF ABBBX ABBXA ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHVE ACHXU ACIHN ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACWMK ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEAQA AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFBBN AFDYV AFJLC AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AIMYW AITGF AJBLW AJRNO AJZVZ AKMHD AKQUC ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BDATZ BENPR BGNMA BKNYI BPHCQ BVXVI CCPQU CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMB EMOBN ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GUQSH GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO ICW IHE IHR IHW IJ- IKXTQ IMOTQ INH INR ITC ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ K9- KDC KOV KPH LAK LLZTM M0R M1P M2O M4Y MA- N9A NB0 NPVJJ NQJWS NU0 O93 O9G O9I O9J OAM P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV ROL RPX RRX RSV S16 S27 S37 S3B SAP SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z7W Z81 Z82 Z83 Z87 Z8O Z8Q Z8U Z8V Z8W Z91 ZMTXR ZOVNA ~EX ~KM |
ID | FETCH-gale_healthsolutions_A4527254143 |
ISSN | 0167-6806 |
IngestDate | Tue Aug 20 22:05:14 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-gale_healthsolutions_A4527254143 |
ParticipantIDs | gale_healthsolutions_A452725414 |
PublicationCentury | 2000 |
PublicationDate | 20160601 |
PublicationDateYYYYMMDD | 2016-06-01 |
PublicationDate_xml | – month: 06 year: 2016 text: 20160601 day: 01 |
PublicationDecade | 2010 |
PublicationTitle | Breast cancer research and treatment |
PublicationYear | 2016 |
Publisher | Springer |
Publisher_xml | – name: Springer |
SSID | ssj0009709 |
Score | 4.418937 |
Snippet | The aim of the study is to compare the efficacy of SPIO as a tracer in sentinel node biopsy (SNB) in breast cancer with Tc and patent blue in a multicentre... |
SourceID | gale |
SourceType | Aggregation Database |
StartPage | 281 |
SubjectTerms | Breast cancer Cancer patients Cancer research Comparative analysis Ferric oxide Intellectual property Iron compounds Tracers (Biology) |
Title | The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide |
Volume | 157 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3bS8MwFMaD7kF8Ea94Nw_iS6lsbdemvs2hDGFDZMLeRpYlo-g6WTtQ_3pPLmtaEaa-lFLWrOsvS0_S7zsHocswCkUs6sKtU6_pBh6PXCqI745k6vaYwCRDlQPq9sLOc_AwaA6srFm5S_LRNfv80VfyH6pwDLhKl-wfyBaNwgHYB76wBcKw_TXjHsweEwb_-TRPulTWfIDv1RZmVq4x6GSLNz53ZKrvKZ2k0rvoSIubM3tPxhU90K3UqedSDsbgBJMNSBvgCll6MU5Dcy80z2hqyhpLfSQt4nSdugB6oFnneeTQYlmpr15HmcLGMCOwtjSaTReZOauXvGbO0wefUJMCYLlM0QitnKqyTFleyoQhOiT1sDIW62zVptN55ZFVV3apZsz-9iQr9IWtoOlFnq5wvu43ZE0F0rbSnzjS0p_lFZjHcSmw6G-jLTMjwC2Ndwet8XQXbXSN5mEPdYAy1pTxkjJWlG8wxZYxngmsGOMyYywZY8V4H13d3_XbHVdexVAbYIv-ObQ_xj9AtXSW8kOEqU98KqNfFgWBiHnMGMT6go8J8-i4QY7QxYrGjld-4gRtWpKnqJbPF_wMQrB8dK7u5xfaCD6J |
link.rule.ids | 314,780,784 |
linkProvider | ProQuest |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Nordic+SentiMag+trial%3A+a+comparison+of+super+paramagnetic+iron+oxide&rft.jtitle=Breast+cancer+research+and+treatment&rft.au=Karakatsanis%2C+Andreas&rft.au=Christiansen%2C+Peer+Michael&rft.au=Sund%2C+Malin&rft.au=Rasmussen%2C+Nils+Ryegaard&rft.date=2016-06-01&rft.pub=Springer&rft.issn=0167-6806&rft.volume=157&rft.issue=2&rft.spage=281&rft.externalDBID=n%2Fa&rft.externalDocID=A452725414 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-6806&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-6806&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-6806&client=summon |